Related Experiment Video
Updated: Jan 25, 2026

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
Published on: August 11, 2008
Emerging erm(B)-Mediated Macrolide Resistance Associated with Novel Multidrug Resistance Genomic Islands in
Dejun Liu1,2, Weiwen Liu1,3, Ziquan Lv3
1Beijing Advanced Innovation Center for Food Nutrition and Human Health, College of Veterinary Medicine, China Agricultural University, Beijing, China.
Abstract:
The rapid dissemination of the macrolide resistance gene erm(B) will likely compromise the efficacy of macrolides as the treatment of choice for campylobacteriosis. More importantly, erm(B) is always associated with several multidrug resistance genomic islands (MDRGIs), which confer resistance to multiple other antimicrobials. Continuous monitoring of the emergence of erm(B) and analysis of its associated genetic environments are crucial for our understanding of macrolide resistance in Campylobacter In this study, 290 Campylobacter isolates (216 Campylobacter coli isolates and 74 Campylobacter jejuni isolates) were obtained from 1,039 fecal samples collected in 2016 from pigs and chickens from three regions of China (344 samples from Guangdong, 335 samples from Shanghai, and 360 samples from Shandong). Overall, 74 isolates (72 C. coli isolates and 2 C. jejuni isolates) were PCR positive for erm(B). Combined with data from previous years, we observed a trend of increasing prevalence of erm(B) in C. coli Pulsed-field gel electrophoresis analyses suggested that both clonal expansion and horizontal transmission were involved in the dissemination of erm(B) in C. coli, and three novel types of erm(B)-associated MDRGIs were identified among the isolates. Furthermore, 2 erm(B)-harboring C. jejuni isolates also contained an aminoglycoside resistance genomic island and a multidrug-resistance-enhancing efflux pump, encoded by RE-cmeABC Antimicrobial susceptibility testing showed that most of the isolates were resistant to all clinically important antimicrobial agents used for the treatment of campylobacteriosis. These findings suggest that the increasing prevalence of erm(B)-associated MDRGIs might further limit treatment options for campylobacteriosis.
Insights
The macrolide resistance gene erm(B) is spreading rapidly in Campylobacter, often linked to multidrug resistance genomic islands. This increases antimicrobial resistance, limiting treatment options for campylobacteriosis.
Area of Science:
- Veterinary Microbiology
- Antimicrobial Resistance
- Genomics
Background:
- Macrolide resistance gene erm(B) is a growing concern for treating campylobacteriosis.
- This gene is frequently associated with multidrug resistance genomic islands (MDRGIs), conferring resistance to multiple antimicrobials.
- Understanding the spread and genetic context of erm(B) in Campylobacter is vital.
Purpose of the Study:
- To investigate the prevalence and genetic environment of the erm(B) gene in Campylobacter isolates from food-producing animals in China.
- To analyze the dissemination mechanisms and identify novel MDRGIs associated with erm(B).
Main Methods:
- Collected 1,039 fecal samples from pigs and chickens across three regions in China.
- Screened 290 Campylobacter isolates (C. coli and C. jejuni) for the erm(B) gene using PCR.
- Performed pulsed-field gel electrophoresis (PFGE) to analyze genetic relatedness and dissemination.
- Identified novel MDRGIs and characterized resistance mechanisms in C. jejuni isolates.
Main Results:
- 74 out of 290 Campylobacter isolates (25.5%) were positive for erm(B), predominantly in C. coli (72/216).
- A trend of increasing erm(B) prevalence in C. coli was observed over time.
- PFGE indicated both clonal expansion and horizontal gene transfer contributed to erm(B) dissemination.
- Three novel erm(B)-associated MDRGIs were identified.
- Two C. jejuni isolates harbored erm(B) along with an aminoglycoside resistance island and RE-cmeABC efflux pump.
- Most isolates exhibited resistance to multiple clinically important antimicrobials.
Conclusions:
- The increasing prevalence of erm(B) and associated MDRGIs in Campylobacter poses a significant threat to public health.
- These findings highlight the urgent need for continuous monitoring and control strategies to combat antimicrobial resistance in foodborne pathogens.
- Treatment options for campylobacteriosis may be further compromised by the spread of these resistance genes.
More Related Videos
09:29In Vivo Investigation of Antimicrobial Blue Light Therapy for Multidrug-resistant Acinetobacter baumannii Burn Infections Using Bioluminescence Imaging
Published on: April 28, 2017
08:45Whole Genome Sequencing of Candida glabrata for Detection of Markers of Antifungal Drug Resistance
Published on: December 28, 2017
Related Concept Videos
Resistivity
Resistance
Resistance and Conductance
Various factors impact the resistance of a conductor. Spiraling in stranded conductors increases their...
Equivalent Resistance
Vascular Resistance
The primary determinants of vascular resistance are vessel diameter, blood viscosity, and vessel length. Among these, vessel diameter plays the most significant role due to the fourth power relationship described by...
Rolling Resistance
For instance, imagine a hard cylinder rolling on a comparatively soft surface. The cylinder's weight compresses the surface beneath it. As the cylinder moves, the material in front of it slows down due to...